
Tonix Pharmaceuticals (TNXP) Stock Surges Following FDA Regulatory Update
After a major regulatory update, Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) saw a sharp increase in the value of its shares. TNXP shares were up
Home » NASDAQ:TNXP
After a major regulatory update, Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) saw a sharp increase in the value of its shares. TNXP shares were up
Following the announcement that Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) will be attending a big investor event, the company’s stock value surged sharply. The most
In premarket trading session, Tonix Pharmaceuticals Holding Corp. (TNXP) stock had surged by 2.46% to $1.25 at last check. TNXP stock previously closed the session at
Tonix Pharmaceuticals Inc. (NASDAQ: TNXP) stock declined by 8.67% in the last trading close, whereas the TNXP stock price rises by 6.57% during pre-market after
NanoVibronix Inc. (NASDAQ: NAOV) shares are trading down -4.55% at $1.05 at the time of writing after announcing $6.0 million private placement. Company’s 52-week ranged
China Automotive Systems Inc. (CAAS) stock soared 2.38% to $10.75 in the pre-market trading after reporting that it shipped approximately 120,000 units from its portfolio
Alterity Therapeutics Limited (ATHE) stock plunged -10.31% to $2.0 in the pre-market trading after the company announced the approval of a US patent for the
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.